RITUXIMAB BIOSIMILAR RTXM83 POST-MARKETING SURVEILLANCE IN BRAZIL: EVALUATION OF THE ADVERSE EVENTS SPONTANEOUSLY REPORTED TO PHARMACOVIGILANCE AM Silva, E Honda, TTWO Watanabe, ALMT Borsoi

RITUXIMAB WITH INVOLVED FIELD IRRADIATION FOR EARLY-STAGE DIFFUSE LARGE CELL LYMPHOMA Vera Kovalskaya, Natalya Falaleeva, Stanislav Shklyaev, Andrey Chelmakov, Ludmila Grivtsova, Marwa Abdelgawad, Ahmed Mubarek

DIFFUSE LARGE CELL LYMPHOMAS WITH RESTRICTED SOURCES Suzana Krasniqi